<?xml version="1.0" encoding="UTF-8"?>
<p>The HR regions of SARS-CoV and SARS-CoV-2 S protein share a high degree of conservation, and the described small molecules as fusion inhibitors can have potential applications in inhibiting SARS-CoV-2 fusion. Indeed, targeting virus surface protein is a promising antiviral strategy, whether inhibiting RBD or S2 domain.</p>
